Company intelligence / Profile preview

Quadria Bio

Singapore, Singapore

Ownership: Private
Employees: ~27
Development stage: Other

Overview

Quadria Capital is Asia’s leading independent healthcare private equity investor, managing over $4 billion AUM and investing in 27 companies in South and Southeast Asia across healthcare delivery, life sciences, medical technology, and pharmaceutical manufacturing. It drives growth and impact through minority or significant stakes in firms addressing pivotal health challenges and market gaps

Therapeutic areas: GastroenterologyOtherNephrologyOncology
Modalities: small moleculesbiologicsmedical devicesdiagnosticshealthcare services
Industry: Investors

Partnerships

Burrill & CompanyHeritas Venture FundHealthQuad

Beyond the preview

Go deeper on Quadria Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Quadria Bio.

Explore the full profile